Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Square Brussels Convention Centre

Mar 12, 2024 9:00 AM - Mar 14, 2024 4:00 PM

Glass Entrance, Mont des Arts/Kunstberg, 1000 Brussels, Belgium

DIA Europe 2024

Deep Dive into the Impact of the New Pharmaceutical Legislation on Regulatory Operations: The Impact on Data, Technology, and Processes in Regulatory Affairs

Session Chair(s)

Remco  Munnik

Remco Munnik

President, IRISS Forum, Spain

Building on the DIAmond session planned on the topic of ‘The New Pharmaceutical Legislation’ - This session will deep dive into its impact on Regulatory Operations; highlighting the role of automation and interoperability within regulatory affairs in Europe and how sector hopes to achieve regulatory efficiency from the process, data and technology point of view. The session will also be complemented by sharing a case study that will deep dive into electronic product information to address what is perceived as missing both from a content and technical point of view.

Learning Objective : After this session, participants should recognize the impact of the implementation of the new EU pharmaceutical legislation on Regulatory Affairs. Be able to describe and discuss the impact on internal processes and systems, while analyzing priorities and decide on crucial initiatives of the company´s Regulatory strategy

Speaker(s)

Remco  Munnik

Remco Munnik

President, IRISS Forum, Spain

New Pharmaceutical Legislation: The Impact on Data, Technology, and Processes in Regulatory Affairs

Juan  Garcia-Burgos, MD, PHD

Juan Garcia-Burgos, MD, PHD

Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands

Impact of the New Pharmaceutical Legislation on EMA's Strategy and Roadmap

Vada  Perkins, MS

Vada Perkins, MS

Vice President, Global Head of Regulatory Intelligence & Policy, Boehringer Ingelheim, United States

Impact on Industry's Regulatory Operations Systems and Processes

Paul-Etienne  Schaeffer, PHARMD

Paul-Etienne Schaeffer, PHARMD

Life Sciences Regulatory Affairs Manager, AESGP, Belgium

Building a Healthier and Empowered Society: Package Leaflet Content Well-Needed Improvements

Julie  Spony, MA

Julie Spony, MA

Policy Officer, European Patients' Forum, Belgium

Panelist

Elizabeth  Scanlan, PHD, MSC

Elizabeth Scanlan, PHD, MSC

ePI Product Owner, European Medicines Agency, Netherlands

Panelist

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.